On Dec. 3, 2020, six biopharma executives joined Pharmaceutical Executive to discuss diversity and inclusion (D&I) in the industry. Michael J. Hennessy Jr., president and CEO of MJH Life Sciences, parent company of Pharmaceutical Executive, welcomed the panel to the closed virtual roundtable. He commented on the racial unrest of 2020 that brought this topic […]

Mr. Culley joined Lineage as Chief Executive Officer in September 2018. Prior to joining Lineage, Mr. Culley served from August 2017 to September 2018 as interim Chief Executive Officer at Artemis Therapeutics, Inc. (ATMS). Mr. Culley previously served as Chief Executive Officer of Mast Therapeutics, Inc. (MSTX), from 2010, and was also a member of […]

NeuroRx has reported that preliminary results from its Phase IIb/III trial of Zyesami (aviptadil, previously RLF-100) showed it reduced hospital stay among patients with respiratory failure due to critical Covid-19. Zyesami is a synthetic form of human Vasoactive Intestinal Peptide (VIP). The study was carried out in partnership with Relief Therapeutics and had 203 patients. […]